Southern Utah University · Cedar City, UT

The Biological Nanoparticles of the Future

Advancing drug delivery and diagnostics through the science of extracellular vesicles and biological nanoparticle engineering.

Our ResearchPublications

Principal Investigator

Dr. Jessica Pullan

Dr. Jessica Pullan

Assistant Professor of Chemistry

I am a pharmaceutical chemist with a focus on nanoparticles. Research interest include nanoparticle drug delivery and nanoparticle diagnostics. Looking specifically at extracellular vesicles.

14+Publications
2Book Chapters
2025Impact Award
2026Distinguished Scholarly Activity Award

Background

Positions & Education

Positions
1996–Now
Badass
Life
2022–Now
Assistant Professor, Chemistry
Southern Utah University · Chemistry
Education
2021
Ph.D. Pharmaceutical Sciences
North Dakota State University · Fargo, ND
Advisor: Dr. Sanku Mallik
2021
College Teaching Certificate
North Dakota State University · Fargo, ND
2017
B.S. Chemistry
Southern Utah University · Cedar City, UT

Recognition

Awards & Honors

Focus Areas

Research Interests

Our lab investigates how biological and synthetic nanoparticles can be engineered to detect and treat disease at the molecular level.

01

Nanoparticle Drug Delivery

Designing lipid-based and biological nanoparticles to deliver therapeutic agents more precisely, with the goal of improving treatment effectiveness while reducing unwanted side effects.

02

Extracellular Vesicles

Studying tiny particles naturally released by cells that can carry proteins, lipids, and genetic material. The lab explores how extracellular vesicles, including those derived from bovine milk, may be modified for future use in drug delivery and diagnostics.

03

Nanoparticle Diagnostics

Developing nanoparticle-based tools that may help detect or visualize disease in less invasive ways, including biological platforms with potential imaging applications.

04

GDF-15 Targeting

Investigating the role of GDF15 in hyperemesis gravidarum, a severe pregnancy condition marked by extreme nausea and vomiting, with the long-term goal of supporting more targeted treatment strategies.

05

Oncology Applications

Exploring new therapeutic approaches for aggressive cancers, including pancreatic cancer, triple-negative breast cancer, and glioblastoma, by studying drug delivery platforms, tumor biology, and molecular targets.

06

Clinical Translation

Examining the steps needed to move promising laboratory discoveries toward patient care, including safety, compatibility, experimental design, and the practical challenges of developing nanoparticle-based therapies.

Partners

Collaborations

Rocky Vista University

Exploring GDF-15

People

The Team

Alumni

Charlie CannonPhD student at Stanford
Undergraduate Researcher
2006–2019

Culture

Our Lab Culture

The Pullan Lab is committed to rigorous science, student mentorship, and collaborative research. Students are trained to think critically, design thoughtful experiments, communicate clearly, and connect chemistry to meaningful biomedical questions. Our lab values curiosity, accountability, teamwork, and the development of young scientists prepared for careers in research, medicine, pharmacy, and biotechnology.

Selected Works

Recent Publications

Peer-reviewed articles and book chapters. Full bibliography →

2025
The Role of Pain Medications in Modulating Peripheral Nerve Injury Recovery
Allgood JE, Whitney L, Goodwin J, Chong BSH, Brooks AE, Pullan JE · The Journal of Clinical Pharmacology, 65(4), 411–423
Journal
2024
Hydrogels for Use in a Bioprinted Pancreatic Cancer Drug Testing Platform
Rehovsky C, Bajwa DS, Mallik SM, Pullan JE, Ara I · Materials Today Communications, 39, 108925
Journal
2024
How Schwann Cells Are Involved in Brain Metastasis
Allgood JE, Roe A, Pullan JE · Neuroglia, 5(2), 155–164
Journal
2024
GDF15 Targeting for Treatment of Hyperemesis Gravidarum
Thygerson J, Oyler D, Thomas J, Muse B, Brooks BD, Pullan JE · Medicines, 11(7), 17
Journal
2023
Dailey KM, Pullan JE, Shreffler JW, Delgado A, Jacobson RI, Johnson PR, Orr M, Kim J, Mallik S, Brooks AE · PLOS ONE, 18(11), e0289183
Journal
2022
Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells
Pullan JE, Dailey KM, Bhallamudi S, Feng L, Alhalhooly L, Froberg J, Molden T, Venkatachalem S, Choi Y, Brooks AE, Mallik S · ACS Applied Bio Materials, 5(5), 2163–2175
Journal
2021
Pierce KM, Miklavcic WR, Cook KP, Sweitzer Hennen M, Bayles KW, Hollingswoth MA, Brooks AE, Dailey KM, Pullan JE · Nanomaterials, 11(11), 3018
Journal
2020
Using Nanoparticles in the Delivery of Natural Chemotherapeutics for Breast Cancer
Pullan JE, Mamoon B, Mallik S · Elsevier NPDD Book, Vol. 5, Ch. 10
Chapter
View All Publications

On the Calendar

Upcoming Events

May 6, 2026
Test Event
The Collesium

Teaching

Courses

CHEM 4990
fall 2026

Chemical Literature and Seminar

Media

Press & Media

Dr. Jessica Pullan’s research uses chemistry and molecular biology to better understand complex diseases and identify more targeted approaches to treatment. Her work includes studying hyperemesis gravidarum, a severe pregnancy condition, by investigating how genetic variation in GDF15 may contribute to extreme nausea and vomiting. She also studies glioblastoma, an aggressive brain cancer, with a focus on how molecules such as SPARCL1 behave differently across regions of a tumor. In addition, her lab examines extracellular vesicles, tiny cell-released particles that may have future uses in diagnostics, drug delivery, and disease monitoring. Across these areas, her research connects laboratory science with real-world medical problems.

For media inquiries, please email.

Get In Touch

Contact & Location

Institution
Southern Utah University Department of Chemistry
Office
SC 014
Phone
435-586-7963
Spring 2026

Please email for appointments outside of office hours.

Send a Message

Fill out the form and we'll get back to you.